ABH Healthcare IPO Day 2 Live: Total hits 1.03x; Retail jumps 26% - Check analysts view and more
- ABH Healthcare IPO reached 1.03x total subscription on Day 2.
- Retail category surged 26.0% intra-day, moving from 0.73x to 0.92x.
- QIBs remain heavily subscribed at 8.37x, unchanged from Day 1.
- The company operates a 150-bed multi-specialty hospital in Ferozepur, Punjab.
- Financials show revenue growth from ₹41.39 crores in FY24 to ₹52.59 crores in FY26.

*this image is generated using AI for illustrative purposes only.
ABH Healthcare’s IPO achieved full subscription on Day 2, crossing the 1x mark at 1.03x by close of business. The milestone was driven by a sharp 26.0% intra-day jump in Retail subscriptions, which rose from 0.73x to 0.92x in the final hours of trading.
Subscription Status
The issue is now fully subscribed, with the Total figure ticking up from 0.94x to 1.03x in the final hours. While Qualified Institutional Buyers (QIBs) held steady at 8.37x, Retail investors provided the critical momentum needed to close the gap.
| Category | Day 1 (24-08-2026) | Day 2 (25-08-2026) | Day 3 (26-08-2026) |
|---|---|---|---|
| QIB | 3.45x | 8.37x | 8.37x |
| NII (bHNI) | 0.07x | 0.13x | 0.20x |
| NII (sHNI) | 0.01x | 0.18x | 0.16x |
| Retail | 0.31x | 0.62x | 0.92x |
| Total | 0.37x | 0.88x | 1.03x |
Intra-day timeline on 26-08-2026
Retail activity intensified after noon, pushing the overall subscription past the full subscription threshold.
| Time (IST) | QIB | NII (bHNI) | Retail | Total |
|---|---|---|---|---|
| 11:15 | 8.37x | 0.14x | 0.73x | 0.94x |
| 12:15 | 8.37x | 0.14x | 0.79x | 0.96x |
| 13:15 | 8.37x | 0.14x | 0.82x | 0.98x |
| 14:15 | 8.37x | 0.14x | 0.85x | 1.00x |
| 15:15 | 8.37x | 0.14x | 0.89x | 1.01x |
| 16:15 | 8.37x | 0.16x | 0.92x | 1.03x |
Momentum highlights:
- Retail: Jumped +26.0% today (from 0.73x to 0.92x)
- Total: Jumped +9.6% today (from 0.94x to 1.03x)
About the Company
ABH Healthcare Limited operates a 150-bed multi-specialty tertiary care hospital under the "Anil Baghi Hospital" brand in Ferozepur, Punjab. Founded in 2021 and acquiring the hospital business in 2022, it offers 25 medical specialties including cardiac sciences and neurology. The company is led by U.S.-trained doctors Dr. Kamal Baghi (MD) and Dr. Saurabh Baghi (CEO).
Financial Highlights
The company reported consistent revenue growth over the last three years. Total equity increased from ₹6.35 crores in FY24 to ₹17.34 crores in FY26.
| Particulars | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue (₹ crores) | 41.39 | 49.32 | 52.59 |
| PAT (₹ crores) | 1.66 | 5.35 | 5.64 |
| Total Equity (₹ crores) | 6.35 | 11.69 | 17.34 |
Revenue grew steadily from ₹41.39 crores in FY24 to ₹52.59 crores in FY26. Profit after tax also improved significantly, rising from ₹1.66 crores to ₹5.64 crores in the same period.
Objects of the Issue
- Repayment/prepayment of certain borrowings: ₹17.00 crores
- Funding working capital requirements: ₹5.00 crores
- Funding inorganic growth through unidentified acquisitions and general corporate purposes
Risk Factors
- Limited operating history as a company since incorporation in March 2021.
- Geographic revenue concentration risk with 100% revenue from its single hospital in Ferozepur.
- High debt-to-equity ratio of 3.20 in Fiscal 2026, posing funding risks.
Key Dates
- Close Date: 2026-08-27
- Allotment Date: 2026-08-28
- Listing Date: 2026-09-01
How might the high debt-to-equity ratio of 3.20 impact ABH Healthcare's ability to execute its planned inorganic growth and acquisitions post-IPO?
What are the potential risks associated with the company's 100% revenue concentration in a single hospital location in Ferozepur, and what is the strategy for geographic diversification?
Given the sharp late-day retail surge, how likely is it that the stock will experience significant volatility or a 'listing pop' on September 1st?



























